STRATEGY: COLLABORATIVE, FLEXIBLE PARTNERSHIPS FOR SHARED SUCCESS

Partnering

Capsidvax pursues strategic partnerships to advance preclinical candidates through clinical proof of concept and commercialization

Through strategic alliances, licensing arrangements, and research collaborations, we apply a flexible, creative approach to building partnerships that unlock shared value and capture upside beyond what either party could achieve on its own.

PARTNERSHIP AREAS Capsidvax contributes product expertise and initial R&D funding, while the partner provides the resources required to advance the candidate through clinical proof-of-concept and beyond.